CONTRA-MAB
Live / Registered — Registered (as of 07 Apr 2020)
What this means for you
Registered since 07 Apr 2020. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 88081271
- Registration number
- 6029997
- Mark type
- Stylized text
- Filed
- 16 Aug 2018
- Published for opposition
- 05 Feb 2019
- Registered
- 07 Apr 2020
- Attorney of record
- Andrew D. Skale
Goods and services
- Class 005 — Pharmaceuticals: Genetically engineered proteins for diagnostic purposes; gene therapy and proteins, namely, antibodies and fusion proteins for the treatment of cancer; pharmaceutical substances and preparations namely, genetically engineered proteins for medical diagnostic use; pharmaceutical and biochemical preparations for the treatment of cancer; Biochemicals, namely, engineered proteins for the regulation of human, animal, plant, viral and microbial genes for clinical and medical laboratory use in human and animal therapeutics for the treatment of cancer, DNA diagnostics and bioinformatics for medical diagnostic purposes
Owner
- INHIBRX BIOSCIENCES, INC., LA JOLLA, CA, US
- INHIBRX, INC., La Jolla, CA, US
- INHIBRX, INC., La Jolla, CA, US
- INHIBRX, INC., La Jolla, CA, US
Prosecution history
- 07 Apr 2025 — COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
- 13 Jun 2024 — AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
- 07 Apr 2020 — REGISTERED-PRINCIPAL REGISTER
- 04 Mar 2020 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 03 Mar 2020 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 20 Feb 2020 — STATEMENT OF USE PROCESSING COMPLETE
- 28 Jan 2020 — USE AMENDMENT FILED
- 12 Feb 2020 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 28 Jan 2020 — TEAS STATEMENT OF USE RECEIVED
- 29 Aug 2019 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 27 Aug 2019 — SOU EXTENSION 1 GRANTED
- 27 Aug 2019 — SOU EXTENSION 1 FILED
- 27 Aug 2019 — SOU TEAS EXTENSION RECEIVED
- 02 Apr 2019 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 05 Feb 2019 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED